Lv63
1960 积分 2022-03-28 加入
Short‐term effect of low‐dose rituximab on myasthenia gravis with muscle‐specific tyrosine kinase antibody
2小时前
已完结
Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis
6小时前
已完结
Rituximab treatment of myasthenia gravis: A systematic review
1天前
已完结
Long-term safety of cyclical rozanolixizumab in patients with generalized myasthenia gravis: Results from the Phase 3 MycarinG study and an open-label extension
2天前
已完结
Rozanolixizumab in generalized myasthenia gravis: Pooled analysis of the Phase 3 MycarinG study and two open-label extensions
2天前
已完结
CD47 limits antibody dependent phagocytosis against non-malignant B cells
5天前
已完结
Opportunities and limitations of B cell depletion approaches in SLE
5天前
已完结
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
12天前
已完结
Heterogeneity in myasthenia gravis: considerations for disease management
12天前
已完结
Myasthenia gravis: subgroup classification and therapeutic strategies
12天前
已完结
皖公网安备34019202002308
